1. Home
  2. SEZL vs COGT Comparison

SEZL vs COGT Comparison

Compare SEZL & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sezzle Inc.

SEZL

Sezzle Inc.

N/A

Current Price

$137.36

Market Cap

5.3B

Sector

Finance

ML Signal

N/A

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

N/A

Current Price

$26.70

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SEZL
COGT
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Financial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.5B
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
SEZL
COGT
Price
$137.36
$26.70
Analyst Decision
Buy
Strong Buy
Analyst Count
7
12
Target Price
★ $192.67
$55.82
AVG Volume (30 Days)
575.4K
★ 1.9M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 4.02
N/A
Revenue
★ $450,279,000.00
$7,871,000.00
Revenue This Year
$42.30
N/A
Revenue Next Year
$26.74
$5,819.52
P/E Ratio
$36.42
★ N/A
Revenue Growth
★ 66.08
N/A
52 Week Low
$52.14
$26.36
52 Week High
$195.71
$43.73

Technical Indicators

Market Signals
Indicator
SEZL
COGT
Relative Strength Index (RSI) 47.03 36.08
Support Level $114.05 N/A
Resistance Level $185.87 $37.34
Average True Range (ATR) 11.76 1.77
MACD -1.08 -0.36
Stochastic Oscillator 27.95 6.38

Price Performance

Historical Comparison
SEZL
COGT

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. The Sezzle Platform offers a payments solution for consumers in the United States and Canada that has the ability to instantly extend credit at the point-of-sale, allowing consumers to purchase and receive merchandise while paying in installments over time. Consumers pay a portion of the purchase price at the point-of-sale as a down payment, and then pay off the remaining amount over time through scheduled payments. It also offer the ability to pay-in-full using the Sezzle Platform. Its operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: